Neurology • Vol 104 • No 6
Comparative Performances of 4 Serum NfL Assays, pTau181, and GFAP in Patients With Amyotrophic Lateral Sclerosis
February 2025 • Etienne Mondésert, Constance Delaby, Elisa De La Cruz, Jens Kühle, Pascal Benkert, Nicolas Pradeilles, Marie Duchiron, Mehdi Morchikh, William Camu, …
This study provides Class II evidence that serum NfL levels are useful in identifying over 80% of patients with ALS and predicting survival in patients with ALS compared with pTau181 and GFAP levels.